Similarly, in in vivo models, PRR11 promoted xenograft tumor growth in tumor size, weight and Ki-67 expression in TSCC, NSCLC, GC, CRC, HCC and Ovarian cancer [2,6,8,9,11,13,19,20]. This evidence concerns the gene MKI67 and hepatocellular carcinoma.